Priscille Bourquelot

Priscille Bourquelot currently serves as the Executive Medical Director at BeiGene, where responsibilities include overseeing the Global group focused on hematological malignancies since October 2022. Prior to this role, Priscille held multiple positions at Sandoz from August 2015 to October 2022, culminating as Sr Global Program Medical Director, where efforts were directed towards innovative global development strategies for biopharmaceuticals and biosimilars in oncology. Priscille's extensive experience also includes a significant tenure at Novartis from May 2006 to December 2014, leading global clinical development programs that advanced compounds in multiple myeloma and chronic myeloid leukemia. Earlier career milestones include serving as VP of Clinical and Therapeutic Research at INSERM and holding positions at Roche Pharmaceuticals and various academic institutions, underpinned by a strong educational background with a Medical Doctorate in Internal Medicine and Hematology from Pierre and Marie Curie University and research fellowship experiences at Princeton University.